Status:
COMPLETED
A Sibling Oocyte Study- Comparison of ZyMotTM Microfluidics Device to Density Gradient for Sperm Selection During ICSI
Lead Sponsor:
NYU Langone Health
Conditions:
ART
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The primary objective of this study is to evaluate whether the percentage of good quality embryo formation following Intracytoplasmic Sperm Injection (ICSI) is improved with the use of ZyMot method of...
Detailed Description
During an in vitro fertilization (IVF) cycle, eggs are removed from a woman's ovaries via a minor surgical procedure and are inseminated with sperm in order to create embryos. The insemination process...
Eligibility Criteria
Inclusion
- Inclusion Criteria for Patients:
- Patient(s) over 18 years of age
- Patient(s) capable of providing informed consent
- Use or possible use of ICSI for oocyte insemination
- At least 6 mature oocytes at time of insemination via ICSI
- Exclusion Criteria for Patients:
- Patient under 18 y/o
- Patients not capable of providing informed consent
- Use of IVF for insemination
- Less than 6 mature oocytes at time of rertrieval
- Anonymous donor sperm source
- Surgically retrieved sperm
- Sperm sample not sufficient for use with ZyMot device
- Inclusion Criteria for Donors:
- Donor(s) over 18 years of age
- Donor(s) capable of providing informed consent
- Use of ejaculate sperm, fresh or frozen, for insemination
- Sufficient sperm for use of ZyMot
- Exclusion Criteria for Donors:
- 1\. Anonymous donors
Exclusion
Key Trial Info
Start Date :
June 18 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 29 2021
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT04818593
Start Date
June 18 2021
End Date
November 29 2021
Last Update
June 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Reproductive Specialists of NY
New York, New York, United States, 10016